Your Advantages of Stem Cell Preservation

Preservation of our healthy adult stem cells as preventive measure on the highest level and in accordance with the latest scientific and technologic developments will be as self-evident as vaccination is today.

Prevention can hardly be any more intelligent!

 

Advantages of Preservation

  • Biological life insurance as preventive health care
  • Back-up copy of your young and healthy stem cells, as our genes are continuously exposed to environmental influences (viral infections, energetic radiation of earth and sun, environmental pollutants) that may cause considerable changes of the cells
  • Create your spare parts store, as stem cells dispose of a renewal and repair function and replace defective cells
  • Manifold treatment possibilities, in which stem cells even today are of high significance and will play an even bigger role in the future

 

TICEBA Offers Security

  • TICEBA is a company founded and lead by physicians and therefore disposes of the necessary know-how with regard to the handling of stem cells.
  • TICEBA is the only company worldwide disposing of the exclusive license of the patent from Brigham and Women's Hospital, university hospital of the Harvard Medical School in Boston/USA, entitling them to determine and isolate the valuable ABCB5+ stem cells.
  • At TICEBA, everything is in one hand: Thanks to our own cell biological laboratory and our own cryo-equipment, no cell transport is necessary.
  • TICEBA takes a part in several research projects and thereby supports the research of the particularly important ABCB5+ stem cells in order to be able to offer new areas of application and new chances in the future.
News
Clinical Trials

We are now also recruiting patients for further clinical studies in phase I/IIa with allogeneic ABCB5-positive (ABCB5+) mesenchymal stem cells for the following indications: chronic venous ulcer (CVU), diabetic foot ulcer (DFU) and peripheral arterial occlusive disease (PAOD). For more information click HERE.

License

Besides the authorization to manufacture a human medicinal product in accordance with § 13 (1) of the German Medicinal Products Act (AMG) for autologous mesenchymal stem cells, TICEBA is also authorized to manufacture a medicinal product for allogeneic mesenchymal as well as allogeneic limbal ABCB5 + stem cells following a recent extension. For more information click HERE.

The Story of Stem Cells

Review our category "The Story of Stem Cells" with the newest topic "Stem cells in wound healing" HERE.

Newsletter